The clinical trial is a prospective, multicenter, non-randomized trial to evaluate the safety profile of the scaffold in 15 men and women with acute ACL injuries. It will be conducted in The Netherlands, in Europe.
Soft Tissue Regeneration is a medical device company whose aim is to apply its patented proprietary technology comprised of PLLA — a biodegradable polymer — in orthopedic implant devices for regeneration and augmentation of soft tissue.
More Articles on Devices:
Mazor Robotics 2013 Net Loss Shoots to $20M
Advancement in Lateral Spine Technology: Q&A with Vertebral Technologies, Inc. CEO Dr. Jeffrey Felt
EDGE Orthopaedics Receives FDA 510(k) Clearance for BITE Compression Screws
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
